Brief: BCAL Diagnostics To List On ASX After Raising A$10M In IPO
21/07/2021 02:35
July 21 (Reuters) - BCAL Diagnostics Ltd BDX.AX :
* TO LIST ON ASX AFTER RAISING A$10M IN IPO
Source text for Eikon: ID:nASXbZzTWm
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures